Company intelligence / Profile preview

Lexalytics

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Lexalytics’ platform is commercially deployed with leading pharma and biotech firms for improving medical affairs, regulatory compliance, and patient outcomes; the technology has demonstrably reduced medical call times and improved analytics capabilities for medical information departments and commercial teams

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

True North SolutionsGlasshouse HealthBrightAvenirAlternativesPharmaBiogenGenentechSage Therapeutics

Beyond the preview

Go deeper on Lexalytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lexalytics.

Explore the full profile